GDFT Based on PPV Compared With Standard Fluid Therapy in Patients Undergoing Complex Spine Surgery: RCT
Goal Directed Fluid Therapy Based on Pulse Pressure Variation Compared With Standard Fluid Therapy in Patients Undergoing Complex Spine Surgery: a Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
The investigators will do the Goal directed fluid therapy by protocolized fluid management in the experimental group, using PPV to guide the fluid administration, compare with standard fluid management in patients undergoing complex spine surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 11, 2017
CompletedFirst Submitted
Initial submission to the registry
April 24, 2017
CompletedFirst Posted
Study publicly available on registry
May 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2019
CompletedFebruary 5, 2020
February 1, 2020
1.7 years
April 24, 2017
February 2, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
episode of intraoperative hypotension
Blood pressure will be record continuously using arterial catheter in both group. Number of participants and episode of hypotension (defined as SBP \< 90 mmHg or MAP \< 60 mmHg or decrease of SPB \>= 25% from baseline for 5 minutes or need vasopressor) therapy
intraoperative
Secondary Outcomes (1)
unit of blood transfusion
intraoperative and up to 24 hours postoperatively
Study Arms (2)
GDFT group
EXPERIMENTALThe GDFT group will receive 400 ml of 12.5% carbohydrate drink after 6 pm until the bed time in the day before surgery and 200 ml in the morning of the surgery day. Acetate ringer solution will be start at 7:00. After induction PPV will be measure and fluid bolus 200 ml in 10 minutes will be given if PPV \>13 before prone position. During the operation, the patient in GDFT group will receipt fluid therapy according to acceptable PPV
controlled group
OTHERThe carbohydrate drink will not be given. Fluid, blood and blood product administration will be under attending anesthesiologist order.
Interventions
pulse pressure variation will be used to as a goal to guide fluid administration in this group
Eligibility Criteria
You may qualify if:
- ASA 1-3
- elective surgery
- thoracic/lumbar spine surgery \>= 3 levels and duration \>= 3 hours
You may not qualify if:
- Cr \>2 mg/dl or eGFR \< 60 ml/min
- coronary artery disease, congestive heart failure or cardiac arrhythmia
- BMI \>30 kg/m2
- hemodynamic unstable, preoperatively
- uncontrolled hypertension
- respiratory system compliance \< 30 ml/cmH2O
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine Siriraj Hospital
Bangkok Noi, Bangkok, 10700, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2017
First Posted
May 24, 2017
Study Start
April 11, 2017
Primary Completion
December 30, 2018
Study Completion
January 30, 2019
Last Updated
February 5, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share